Qlife – LOI with major industry player in China for Egoo Health


Meet and ask questions to CEO Thomas Warthoe from Qlife on 19 September 2023 at 9.00 AM.Qlife announced that they have signed a Letter of Intent (LOI) with major industry player, Hipro Biotechnology, to introduce Egoo Health to the Chinese market. Qlife anticipate finalizing a comprehensive collaboration agreement by the end of this year.Disclaimer: HC Andersen Capital receives payment from Qlife Holding for a DigitalIR/Corporate Visibility agreement./Claus Thestrup 14-09-2023 4.39PM.